A study on the efficacy of the combination of growth hormone (GH) and gonadotropin releasing hormone analogues (GnRHa) on adult height in children with idiopathic short stature

Completed

• Conditions: Small for Gestational Age (SGA), children with persistent short stature; Nutritional, Metabolic, Endocrine; Other endocrine disorders

• Registration Number: ISRCTN82161629
• Lead Sponsor: Pfizer B.V. (Netherlands) (Pfizer Inc, New York)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-12-19
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

40 adolescents in early puberty, with a height <-2 Standard Deviation Score (SDS) or with a height SDS between -1 and -2, but a predicted adult height SDS <-2

Exclusion Criteria

Disorders or medication influencing growth

Study & Design

• Study Type: Interventional
• Study Design: Not specified